4-aminopyridine has been researched along with Dyspnea in 1 studies
Dyspnea: Difficult or labored breathing.
Excerpt | Relevance | Reference |
---|---|---|
"4-Aminopyridine (4-AP) is a recent treatment indicated to improve walking in patient with multiple sclerosis." | 7.91 | Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine. ( Chabot, F; Chaouat, A; Gomez, E; Guillaumot, A; Petitpain, N; Ribeiro Baptista, B; Valentin, S; Yelehé-Okouma, M, 2019) |
"4-Aminopyridine (4-AP) is a recent treatment indicated to improve walking in patient with multiple sclerosis." | 3.91 | Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine. ( Chabot, F; Chaouat, A; Gomez, E; Guillaumot, A; Petitpain, N; Ribeiro Baptista, B; Valentin, S; Yelehé-Okouma, M, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ribeiro Baptista, B | 1 |
Petitpain, N | 1 |
Gomez, E | 1 |
Yelehé-Okouma, M | 1 |
Valentin, S | 1 |
Guillaumot, A | 1 |
Chabot, F | 1 |
Chaouat, A | 1 |
1 other study available for 4-aminopyridine and Dyspnea
Article | Year |
---|---|
Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine.
Topics: 4-Aminopyridine; Antihypertensive Agents; Dyspnea; Female; Humans; Hypertension, Pulmonary; Middle A | 2019 |